Shanghai Universal Biotech Co.Ltd. (301166.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Biotechnology · China · ISIN CNE100005709

Price
30.58 CNY
Market cap
2.65 bn CNY
P/E (2025)
–
P/S (2025)
2.45
Dividend yield
1.96 %
Net margin
-2.12 %
Return on equity (ROE)
-1.14 %
Return on assets (ROA)
-1.00 %

Shanghai Universal Biotech Co.Ltd. financials

Fiscal year20242025
Revenue1.12 bn CNY1.08 bn CNY
Gross profit201.85 m CNY203.57 m CNY
Operating income-25.53 m CNY-41.95 m CNY
EBIT1.86 m CNY-32.76 m CNY
Net income10.15 m CNY-22.95 m CNY
Diluted EPS – continuing operations0.12 CNY-0.26 CNY

Full history since 2019, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Shanghai Universal Biotech Co.Ltd.

Shanghai Universal Biotech Co.,Ltd. distributes and supplies antibodies and protein products. The company offers antibodies, recombinant proteins, detection kits, antigens, and other products, as well as immunology reagents, molecular biology reagents, cell biology reagents and biochemical reagents, as well as reagent kits. It also provides technical services, technology promotion, technology information exchange, scientific and technology training, technology consulting, technology incubation and other services, as well as experimental services and software solutions. The company also sells products online. It serves colleges and universities, research institutes, hospitals, and biomedical companies. The company was founded in 2004 and is based in Shanghai, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.